SAN DIEGO — ChatGPT, an artificial intelligence (AI) tool that can provide headache information, makes significant errors regarding migraine drug treatments but does better when it […]

CHICAGO — Prominent Chinese oncologist Tony Shu-Kam Mok, MD, who presented as first author of a phase 3 non–small cell lung cancer study at ASCO 2024, […]

Glofitamab, a fixed-duration CD20xCD3 bispecific antibody, combined with a chemotherapy regimen of gemcitabine and oxaliplatin (GemOx), shows significant survival benefits in the treatment of patients with […]

MADRID — The chemotherapy-free combination of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) that is standard in treating low-risk acute promyelocytic leukemia (APL) also shows […]

In the wake of a debilitating cyberattack against one of the nation’s largest health care systems, Marvin Ruckle, a nurse at an Ascension hospital in Wichita, […]

The US Food and Drug Administration (FDA) has recently approved Duvyzat (givinostat), the first nonsteroidal therapy for children aged 6 years and older who have all […]

SAN DIEGO — Cognitive impairment, or “brain fog,” is a well-known effect of active migraines, but evidence is mounting that it is also common during interictal […]

VIENNA — The hypothesis that pivotal clinical trials for osteoarthritis (OA)-modifying therapies are not using appropriate designs or endpoints appears to be consistent with the recent […]

Canada’s legalization of cannabis oil and other nonmedical cannabis products in 2018 has not led to better quality control and accurate product labeling, new research suggested. […]